Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone Palmitate vs Oral Risperidone in Schizophrenia Relapse Prevention
NCT00946985Phase 4Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2009
- Primary completion
- Mar 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 12
01
Overview
A Phase 4 trial of paliperidone palmitate in schizophrenia, sponsored by Janssen Pharmaceutical. Started Jun 2009; status: terminated.
02
Drugs
paliperidone palmitate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00946985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00946985.